Vaccination represents one of the greatest public health triumphs; in part due to the effect of
adjuvants that have been included in vaccine preparations to boost the immune responses
through different mechanisms. Although a variety of novel adjuvants have been under
development, only a limited number have been approved by regulatory authorities for
human vaccines. This report reflects the conclusions of a group of scientists from academia,
regulatory agencies and industry who attended a conference on the current state of the art in …